(Z)-N-(oxazolidin-2-ylidene)-4-(trifluoromethyl)aniline

ID: ALA2286071

PubChem CID: 76320064

Max Phase: Preclinical

Molecular Formula: C10H9F3N2O

Molecular Weight: 230.19

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  FC(F)(F)c1ccc(/N=C2/NCCO2)cc1

Standard InChI:  InChI=1S/C10H9F3N2O/c11-10(12,13)7-1-3-8(4-2-7)15-9-14-5-6-16-9/h1-4H,5-6H2,(H,14,15)

Standard InChI Key:  MWVQNDBNMCFZKW-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 16 17  0  0  0  0  0  0  0  0999 V2000
   11.4423   -1.6654    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8131   -2.3962    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6296   -2.4394    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.0763   -1.7526    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.7005   -1.0207    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8851   -0.9811    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.8924   -1.7943    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.2643   -2.5220    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.8948   -3.2501    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.4733   -3.8272    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.2010   -3.4553    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.0721   -2.6483    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.6262   -1.6225    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.2553   -0.8944    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   10.1811   -2.3078    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    9.8063   -1.6179    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  4  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12  8  1  0
  1 13  1  0
 13 14  1  0
 13 15  1  0
 13 16  1  0
M  END

Associated Targets(non-human)

oa1 Octopamine receptor (86 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 230.19Molecular Weight (Monoisotopic): 230.0667AlogP: 2.31#Rotatable Bonds: 1
Polar Surface Area: 33.62Molecular Species: NEUTRALHBA: 2HBD: 1
#RO5 Violations: HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 7.26CX LogP: 2.66CX LogD: 2.43
Aromatic Rings: 1Heavy Atoms: 16QED Weighted: 0.80Np Likeness Score: -1.01

References

1. HIRASHIMA A, PAN C, KATAFUCHI Y, TANIGUCHI E, ETO M.  (1996)  Synthesis and Octopaminergic-Agonist Activity of 2-(Arylimino)oxazolidines and 2-(Substituted Benzylamino)-2-oxazolines,  21  (4): [10.1584/jpestics.21.419]

Source